CTC (Chicago Trading Company)’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-212,200
Closed -$5.63M 248
2024
Q4
$5.63M Buy
212,200
+209,329
+7,291% +$5.68M ﹤0.01% 166
2024
Q3
$8.31M Sell
2,871
-2,154
-43% -$62.8K ﹤0.01% 163
2024
Q2
$14.1M Sell
5,025
-1,345
-21% -$37K 0.01% 171
2024
Q1
$17.7M Sell
6,370
-1,816
-22% -$50.4K 0.01% 178
2023
Q4
$23.6M Buy
8,186
+2,817
+52% +$85.2K 0.01% 183
2023
Q3
$17.8M Sell
5,369
-3,889
-42% -$138K 0.01% 199
2023
Q2
$34M Buy
9,258
+254
+3% +$9.89K 0.02% 171
2023
Q1
$36.4M Buy
9,004
+5,007
+125% +$216K 0.02% 164
2022
Q4
$20.5M Sell
3,997
-4,817
-55% -$231K 0.02% 188
2022
Q3
$38.5M Sell
8,814
-2,802
-24% -$136K 0.02% 150
2022
Q2
$60.9M Buy
11,616
+1,722
+17% +$87.8K 0.04% 115
2022
Q1
$51.2M Sell
9,894
-18,683
-65% -$969K 0.02% 139
2021
Q4
$169M Buy
28,577
+19,835
+227% +$983K 0.07% 56
2021
Q3
$37.6M Buy
+8,742
New +$387K 0.02% 95

Other funds holding PFE

CTC (Chicago Trading Company)'s PFE Position: Q1 2025 in Review

CTC (Chicago Trading Company) sold out of Pfizer (PFE) in Q1 2025, closing a stake of 137,445 shares — an estimated $3.65M sold.

CTC (Chicago Trading Company) first reported a position in PFE in Q2 2013 and held it in 13 quarters. The position peaked at $80.6M in Q4 2021. 2,930 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • CTC (Chicago Trading Company) reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
  • CTC (Chicago Trading Company) sold 137,445 Pfizer shares in Q1 2025, an estimated $3.65M.
  • CTC (Chicago Trading Company) first reported a position in Pfizer in Q2 2013 and held it in 13 quarters.
  • CTC (Chicago Trading Company)'s Pfizer position peaked at $80.6M in Q4 2021.
  • 2,930 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on CTC (Chicago Trading Company)'s 13F filing for Q1 2025, filed 16 May 2025.